Skip to main content

Table 1 Pain assessment of CRPS patients before and after PE

From: Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange

ID

Age

Sex

Duration of CRPS (years)

Pre PE NRS

Post PE NRS

HT (cm)

WT (kg)

BMI

Response

Comorbidities

P1

54

F

4

7

3

170

100.9

34.9

Good

Hypothyroidism, B12 deficiency, Iron deficiency, GERD, Seizure,

P2

40

M

11

8

4

195

126

33.1

Good

No past medical history other than CRPS

P3

57

M

> 6

8

2

165

120

44.1

Good

Asthma, DM, OSA, Hypercholestrolemia, Mitochondrial disease

P4

57

F

> 6

8

7

163

51.63

19.4

Poor

Fibromyalgia, Anemia

P5

28

F

7

7

7

160

81.1

31.7

Poor

Grave’s disease, Polycystic ovary syndrome, Migraine, Von Willebrand disease

P6

26

F

> 6

8

7

163

52.27

19.7

Poor

Stiff man syndrome, Seizure disorder

  1. Pain assessment was conducted on CRPS patients before and 2 weeks following PE, using a numerical rating scale (NRS). CRPS patients with a difference in the NRS pain scores (pre PE-post PE) greater than three were considered as responders, while those less than three were classified as poor responders